載入...
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
Glycoprotein IIb/IIIa inhibitors represent a new promising class of antiplatelet medications. Their use in acute coronary syndromes and for patients undergoing percutaneous coronary intervention has been the subject of a number of large controlled trials using both the intravenous and the oral forms...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2001
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC59641/ https://ncbi.nlm.nih.gov/pubmed/11806792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cvm-2-4-171 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|